Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Aset Lancar
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 12.91B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Aset Lancar
Perubahan
Tanggal
Agilent
USD 4.76B
148M
2026-03
Align Technology
USD 2.66B
38.87M
2026-03
Bio Techne
USD 688.05M
50.62M
2026-03
Bio-Rad Laboratories
USD 2.94B
35.9M
2026-03
Bruker
USD 2.1B
108.9M
2026-03
Celltrion
KRW 470.6B
5.07T
2025-12
Charles River Laboratories
USD 1.49B
41.76M
2026-03
Cspc Pharmaceutical
CNY 22.25B
359.48M
2025-12
Danaher
USD 13.94B
1.18B
2026-03
Dentsply International
USD 1.85B
178M
2026-03
Deva Holding AS
TRY 9.13B
1.61B
2023-09
Dianthus Therapeutics
USD 1.12B
710.47M
2026-03
Divis Laboratories Ltd
INR 110.96B
12.53B
2026-03
Edwards Lifesciences
USD 6.23B
510.2M
2026-03
Illumina
USD 2.74B
551M
2026-03
Intuitive Surgical
USD 11.52B
881.5M
2026-03
IQVIA Holdings
USD 6.22B
29M
2026-03
Kangmei Pharma
CNY 6.8B
225.83M
2026-03
Knight Therapeutics
CAD 394.84M
5.86M
2025-12
Laboratorios Farma
EUR 509.33M
128.63M
2023-12
Laboratory Of America
USD 4.56B
538.3M
2026-03
Malin Corporation
EUR 62.6M
26.7M
2024-12
Medical Developments International
AUD 33.75M
1.79M
2025-12
Mesa Laboratories
USD 105.63M
8.2M
2025-12
Mettler Toledo International
USD 1.33B
30.76M
2026-03
Myriad Genetics
USD 312.8M
19.8M
2026-03
Neuren Pharmaceuticals
AUD 332.23M
11.98M
2025-12
OraSure Technologies
USD 240.78M
21.13M
2026-03
Organigram Holdings
CAD 256.54M
28.35M
2025-12
Ovoca Bio
EUR 1.56M
3.39M
2025-06
Pacific Biosciences Of California
USD 369.52M
5.54M
2026-03
Pharma Mar
EUR 273.45M
9.96M
2026-03
Qiagen NV
USD 2B
535.87M
2025-12
Quest Diagnostics
USD 2.57B
188M
2026-03
Quidel
USD 1.38B
70.3M
2026-03
Repligen
USD 1.16B
23.98M
2026-03
Revvity
USD 2.13B
111.43M
2026-03
Sartorius
EUR 1.92B
157.2M
2026-03
Sino Biopharmaceutical
CNY 33.82B
9.13B
2025-06
Thermo Fisher Scientific
USD 22.32B
6.39B
2026-03
Tilray
USD 729.32M
28.18M
2025-09
Waters
USD 3.72B
1.73B
2026-03
Zealand Pharma A/S
15.67B
950.94M
2025-12
Zz Pientze Pharmaceu
CNY 11.43B
728.95M
2026-03
×